Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma

par Jessica E. Sagers, Adam S. Brown, Sasa Vasilijic, Rebecca M. Lewis, Mehmet I. Sahin, Lukas D. Landegger, Roy H. Perlis, Isaac S. Kohane, D. Bradley Welling, Chirag J. Patel, Konstantina M. Stankovic
Publié 2018

Systematic and other reviews: Criteria and complexities

par Robert T. Sataloff, Matthew L. Bush, Rakesh Chandra, Douglas Chepeha, Brian Rotenberg, Edward W. Fisher, David Goldenberg, Ehab Y. Hanna, Joseph E. Kerschner, Dennis H. Kraus, John H. Krouse, Daqing Li, Michael Link, Lawrence R. Lustig, Samuel H. Selesnick, Raj Sindwani, Richard J. Smith, James R. Tysome, Peter C. Weber, D. Bradley Welling
Publié 2021

Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.

par Long-Sheng Chang, Janet L Oblinger, Abbi E Smith, Marc Ferrer, Steven P Angus, Eric Hawley, Alejandra M Petrilli, Roberta L Beauchamp, Lars Björn Riecken, Serkan Erdin, Ming Poi, Jie Huang, Waylan K Bessler, Xiaohu Zhang, Rajarshi Guha, Craig Thomas, Sarah S Burns, Thomas S K Gilbert, Li Jiang, Xiaohong Li, Qingbo Lu, Jin Yuan, Yongzheng He, Shelley A H Dixon, Andrea Masters, David R Jones, Charles W Yates, Stephen J Haggarty, Salvatore La Rosa, D Bradley Welling, Anat O Stemmer-Rachamimov, Scott R Plotkin, James F Gusella, Justin Guinney, Helen Morrison, Vijaya Ramesh, Cristina Fernandez-Valle, Gary L Johnson, Jaishri O Blakeley, D Wade Clapp, Synodos for NF2 Consortium
Publié 2021